Treatment of Cancer‐Associated Venous Thromboembolism with Low‐Molecular‐Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats

The treatment of venous thromboembolism (VTE) in patients with cancer is challenging because these patients have increased risks of both recurrent VTE and major bleeding, along with patient‐specific and cancer‐related factors that influence the approach to treatment. Historically, anticoagulant ther...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncologist
Hlavní autoři: O'Connell, Casey, Escalante, Carmen P., Goldhaber, Samuel Z., McBane, Robert, Connors, Jean M., Raskob, Gary E.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Inc. 2020
Témata:
Special Series: Approach to the Patient with Cancer and Thrombosis
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7794180/
https://ncbi.nlm.nih.gov/pubmed/33275319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13584
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky